Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow-up of US Oncology Research Trial 9735 - Jones, S; Holmes, F A; O'Shaughnessy, J (J Clin Oncol, 2009)